JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2226689, encodeId=7bd42226689b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：内科 经验分享：投稿前先是做了大量的工作，查了很多资料。 投稿后，大概一个多月吧，通知说文章被考虑了，要每个作者填写协议。 后面差不多过了2周时间，说准备接受 然后给了修改，编辑也很认真负责。 大概又过了12天，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 真是太意外了，感觉自己是运气爆棚😏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820006, createdTime=Thu Sep 19 23:26:05 CST 2024, time=2024-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256815, encodeId=94ec225681582, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿周期较长，2-3个月（部分稿件可能需要更长时间，合理安排时间） JAMA接受多种类型的稿件，包括原创研究、系统综述、病例报告等。其中，原创研究需具有创新性，强调多中心设计、随机对照双盲设计。 同时大家在写作时如果引用文献等话要引用近5年文献，同时图表分辨率要达到300dpi，大小最好不要超过10MB。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 22:43:59 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241748, encodeId=52872241e48fe, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学综合 经验分享：简单记录一下，我的个人经验希望能帮到大家。首先在投稿前要做足准备，我查了很多资料，浏览了很多平台，也看了很多往期发表的内容，也从大家经验分享中收获了很多，（感觉整个很有必要，投稿前充分了解一下该期刊）。 投稿7周后，通知说文章被考虑，然后就是作者填写协议。 又过了2周，给了修改意见。然后又过了2周左右，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 确实是挺意外了，没想过竟然真多通过了所有审稿环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:07:27 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210788, encodeId=2a3c2210e88c0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;医学综合;心血管 经验分享：JAMA在2023年度影响因子63.1，LANCET为98.4， BMJ为93.6，NEJM为96.2，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:38:34 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=514456, encodeId=b8945144562f, content=JAMA 前天投的，今天主编给了文章编号，显示under review，有这么快就送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf7e34716, createdName=hangbinglengyu, createdTime=Wed Aug 12 15:19:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142379, encodeId=c52c21423e9c6, content=偏重的研究方向：医学综合 经验分享：不知道Under Review是编辑审还是外审呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Mon Jun 12 15:56:44 CST 2023, time=2023-06-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2140958, encodeId=9832214095887, content=大胆投稿，反复修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 05 20:50:43 CST 2023, time=2023-06-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2133562, encodeId=c5a52133562e7, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：原始论著没投过，但是投了一篇Letter to the Editor，偶然间浏览杂志刚好看到一篇RCT觉得有些地方需要补充，信息缺乏，就花了一两个小时查查文献资料，结合自己的临床经验，写了一个短篇评论，投过去就没管了，大概不到一个月吧，通知说文章被考虑发表，要每个作者填写协议，然后填完大概过了十多天说准备接受，然后给我改了文章，逐字逐句的，挺认真，都是编辑和你邮件往来，大概又过了一个星期，通知We have completed our review of your Letter to the Editor and are pleased to accept it for publication in JAMA. 这也是第一次给这杂志写letter，没想到一击必中，可能运气爆棚了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=538, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160701/IMG57766D0F679469828.jpg, createdBy=d47d28603, createdName=200750383, createdTime=Sat May 13 16:38:33 CST 2023, time=2023-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=544655, encodeId=5518544655ff, content=请求帮助，谁知道这个杂志怎么注册？为什么我要投稿，注册用户，怎么都注册不了？求高人指点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2667, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc8b41136, createdName=chunyangjiang, createdTime=Thu Jul 20 16:14:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544482, encodeId=9b5d544482a9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2024-09-19 ms1000001788820006 来自上海

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：内科
经验分享：投稿前先是做了大量的工作，查了很多资料。
投稿后，大概一个多月吧，通知说文章被考虑了，要每个作者填写协议。
后面差不多过了2周时间，说准备接受
然后给了修改，编辑也很认真负责。
大概又过了12天，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama.
真是太意外了，感觉自己是运气爆棚😏

74 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226689, encodeId=7bd42226689b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：内科 经验分享：投稿前先是做了大量的工作，查了很多资料。 投稿后，大概一个多月吧，通知说文章被考虑了，要每个作者填写协议。 后面差不多过了2周时间，说准备接受 然后给了修改，编辑也很认真负责。 大概又过了12天，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 真是太意外了，感觉自己是运气爆棚😏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820006, createdTime=Thu Sep 19 23:26:05 CST 2024, time=2024-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256815, encodeId=94ec225681582, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿周期较长，2-3个月（部分稿件可能需要更长时间，合理安排时间） JAMA接受多种类型的稿件，包括原创研究、系统综述、病例报告等。其中，原创研究需具有创新性，强调多中心设计、随机对照双盲设计。 同时大家在写作时如果引用文献等话要引用近5年文献，同时图表分辨率要达到300dpi，大小最好不要超过10MB。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 22:43:59 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241748, encodeId=52872241e48fe, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学综合 经验分享：简单记录一下，我的个人经验希望能帮到大家。首先在投稿前要做足准备，我查了很多资料，浏览了很多平台，也看了很多往期发表的内容，也从大家经验分享中收获了很多，（感觉整个很有必要，投稿前充分了解一下该期刊）。 投稿7周后，通知说文章被考虑，然后就是作者填写协议。 又过了2周，给了修改意见。然后又过了2周左右，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 确实是挺意外了，没想过竟然真多通过了所有审稿环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:07:27 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210788, encodeId=2a3c2210e88c0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;医学综合;心血管 经验分享：JAMA在2023年度影响因子63.1，LANCET为98.4， BMJ为93.6，NEJM为96.2，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:38:34 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=514456, encodeId=b8945144562f, content=JAMA 前天投的，今天主编给了文章编号，显示under review，有这么快就送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf7e34716, createdName=hangbinglengyu, createdTime=Wed Aug 12 15:19:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142379, encodeId=c52c21423e9c6, content=偏重的研究方向：医学综合 经验分享：不知道Under Review是编辑审还是外审呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Mon Jun 12 15:56:44 CST 2023, time=2023-06-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2140958, encodeId=9832214095887, content=大胆投稿，反复修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 05 20:50:43 CST 2023, time=2023-06-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2133562, encodeId=c5a52133562e7, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：原始论著没投过，但是投了一篇Letter to the Editor，偶然间浏览杂志刚好看到一篇RCT觉得有些地方需要补充，信息缺乏，就花了一两个小时查查文献资料，结合自己的临床经验，写了一个短篇评论，投过去就没管了，大概不到一个月吧，通知说文章被考虑发表，要每个作者填写协议，然后填完大概过了十多天说准备接受，然后给我改了文章，逐字逐句的，挺认真，都是编辑和你邮件往来，大概又过了一个星期，通知We have completed our review of your Letter to the Editor and are pleased to accept it for publication in JAMA. 这也是第一次给这杂志写letter，没想到一击必中，可能运气爆棚了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=538, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160701/IMG57766D0F679469828.jpg, createdBy=d47d28603, createdName=200750383, createdTime=Sat May 13 16:38:33 CST 2023, time=2023-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=544655, encodeId=5518544655ff, content=请求帮助，谁知道这个杂志怎么注册？为什么我要投稿，注册用户，怎么都注册不了？求高人指点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2667, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc8b41136, createdName=chunyangjiang, createdTime=Thu Jul 20 16:14:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544482, encodeId=9b5d544482a9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2025-03-19 ms5000002977722152 来自上海

审稿速度:3.0 | 投稿命中率:25.0
经验分享：审稿周期较长，2-3个月（部分稿件可能需要更长时间，合理安排时间）
JAMA接受多种类型的稿件，包括原创研究、系统综述、病例报告等。其中，原创研究需具有创新性，强调多中心设计、随机对照双盲设计。
同时大家在写作时如果引用文献等话要引用近5年文献，同时图表分辨率要达到300dpi，大小最好不要超过10MB。

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2226689, encodeId=7bd42226689b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：内科 经验分享：投稿前先是做了大量的工作，查了很多资料。 投稿后，大概一个多月吧，通知说文章被考虑了，要每个作者填写协议。 后面差不多过了2周时间，说准备接受 然后给了修改，编辑也很认真负责。 大概又过了12天，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 真是太意外了，感觉自己是运气爆棚😏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820006, createdTime=Thu Sep 19 23:26:05 CST 2024, time=2024-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256815, encodeId=94ec225681582, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿周期较长，2-3个月（部分稿件可能需要更长时间，合理安排时间） JAMA接受多种类型的稿件，包括原创研究、系统综述、病例报告等。其中，原创研究需具有创新性，强调多中心设计、随机对照双盲设计。 同时大家在写作时如果引用文献等话要引用近5年文献，同时图表分辨率要达到300dpi，大小最好不要超过10MB。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 22:43:59 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241748, encodeId=52872241e48fe, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学综合 经验分享：简单记录一下，我的个人经验希望能帮到大家。首先在投稿前要做足准备，我查了很多资料，浏览了很多平台，也看了很多往期发表的内容，也从大家经验分享中收获了很多，（感觉整个很有必要，投稿前充分了解一下该期刊）。 投稿7周后，通知说文章被考虑，然后就是作者填写协议。 又过了2周，给了修改意见。然后又过了2周左右，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 确实是挺意外了，没想过竟然真多通过了所有审稿环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:07:27 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210788, encodeId=2a3c2210e88c0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;医学综合;心血管 经验分享：JAMA在2023年度影响因子63.1，LANCET为98.4， BMJ为93.6，NEJM为96.2，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:38:34 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=514456, encodeId=b8945144562f, content=JAMA 前天投的，今天主编给了文章编号，显示under review，有这么快就送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf7e34716, createdName=hangbinglengyu, createdTime=Wed Aug 12 15:19:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142379, encodeId=c52c21423e9c6, content=偏重的研究方向：医学综合 经验分享：不知道Under Review是编辑审还是外审呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Mon Jun 12 15:56:44 CST 2023, time=2023-06-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2140958, encodeId=9832214095887, content=大胆投稿，反复修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 05 20:50:43 CST 2023, time=2023-06-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2133562, encodeId=c5a52133562e7, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：原始论著没投过，但是投了一篇Letter to the Editor，偶然间浏览杂志刚好看到一篇RCT觉得有些地方需要补充，信息缺乏，就花了一两个小时查查文献资料，结合自己的临床经验，写了一个短篇评论，投过去就没管了，大概不到一个月吧，通知说文章被考虑发表，要每个作者填写协议，然后填完大概过了十多天说准备接受，然后给我改了文章，逐字逐句的，挺认真，都是编辑和你邮件往来，大概又过了一个星期，通知We have completed our review of your Letter to the Editor and are pleased to accept it for publication in JAMA. 这也是第一次给这杂志写letter，没想到一击必中，可能运气爆棚了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=538, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160701/IMG57766D0F679469828.jpg, createdBy=d47d28603, createdName=200750383, createdTime=Sat May 13 16:38:33 CST 2023, time=2023-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=544655, encodeId=5518544655ff, content=请求帮助，谁知道这个杂志怎么注册？为什么我要投稿，注册用户，怎么都注册不了？求高人指点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2667, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc8b41136, createdName=chunyangjiang, createdTime=Thu Jul 20 16:14:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544482, encodeId=9b5d544482a9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2024-12-10 ms3000001788822132 来自上海

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：医学综合
经验分享：简单记录一下，我的个人经验希望能帮到大家。首先在投稿前要做足准备，我查了很多资料，浏览了很多平台，也看了很多往期发表的内容，也从大家经验分享中收获了很多，（感觉整个很有必要，投稿前充分了解一下该期刊）。
投稿7周后，通知说文章被考虑，然后就是作者填写协议。
又过了2周，给了修改意见。然后又过了2周左右，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 确实是挺意外了，没想过竟然真多通过了所有审稿环节。

31 0

[GetPortalCommentsPageByObjectIdResponse(id=2226689, encodeId=7bd42226689b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：内科 经验分享：投稿前先是做了大量的工作，查了很多资料。 投稿后，大概一个多月吧，通知说文章被考虑了，要每个作者填写协议。 后面差不多过了2周时间，说准备接受 然后给了修改，编辑也很认真负责。 大概又过了12天，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 真是太意外了，感觉自己是运气爆棚😏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820006, createdTime=Thu Sep 19 23:26:05 CST 2024, time=2024-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256815, encodeId=94ec225681582, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿周期较长，2-3个月（部分稿件可能需要更长时间，合理安排时间） JAMA接受多种类型的稿件，包括原创研究、系统综述、病例报告等。其中，原创研究需具有创新性，强调多中心设计、随机对照双盲设计。 同时大家在写作时如果引用文献等话要引用近5年文献，同时图表分辨率要达到300dpi，大小最好不要超过10MB。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 22:43:59 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241748, encodeId=52872241e48fe, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学综合 经验分享：简单记录一下，我的个人经验希望能帮到大家。首先在投稿前要做足准备，我查了很多资料，浏览了很多平台，也看了很多往期发表的内容，也从大家经验分享中收获了很多，（感觉整个很有必要，投稿前充分了解一下该期刊）。 投稿7周后，通知说文章被考虑，然后就是作者填写协议。 又过了2周，给了修改意见。然后又过了2周左右，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 确实是挺意外了，没想过竟然真多通过了所有审稿环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:07:27 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210788, encodeId=2a3c2210e88c0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;医学综合;心血管 经验分享：JAMA在2023年度影响因子63.1，LANCET为98.4， BMJ为93.6，NEJM为96.2，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:38:34 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=514456, encodeId=b8945144562f, content=JAMA 前天投的，今天主编给了文章编号，显示under review，有这么快就送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf7e34716, createdName=hangbinglengyu, createdTime=Wed Aug 12 15:19:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142379, encodeId=c52c21423e9c6, content=偏重的研究方向：医学综合 经验分享：不知道Under Review是编辑审还是外审呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Mon Jun 12 15:56:44 CST 2023, time=2023-06-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2140958, encodeId=9832214095887, content=大胆投稿，反复修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 05 20:50:43 CST 2023, time=2023-06-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2133562, encodeId=c5a52133562e7, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：原始论著没投过，但是投了一篇Letter to the Editor，偶然间浏览杂志刚好看到一篇RCT觉得有些地方需要补充，信息缺乏，就花了一两个小时查查文献资料，结合自己的临床经验，写了一个短篇评论，投过去就没管了，大概不到一个月吧，通知说文章被考虑发表，要每个作者填写协议，然后填完大概过了十多天说准备接受，然后给我改了文章，逐字逐句的，挺认真，都是编辑和你邮件往来，大概又过了一个星期，通知We have completed our review of your Letter to the Editor and are pleased to accept it for publication in JAMA. 这也是第一次给这杂志写letter，没想到一击必中，可能运气爆棚了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=538, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160701/IMG57766D0F679469828.jpg, createdBy=d47d28603, createdName=200750383, createdTime=Sat May 13 16:38:33 CST 2023, time=2023-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=544655, encodeId=5518544655ff, content=请求帮助，谁知道这个杂志怎么注册？为什么我要投稿，注册用户，怎么都注册不了？求高人指点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2667, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc8b41136, createdName=chunyangjiang, createdTime=Thu Jul 20 16:14:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544482, encodeId=9b5d544482a9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2024-06-20 侠胆医心来自伊利诺伊

审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向：肿瘤;医学综合;心血管
经验分享：JAMA在2023年度影响因子63.1，LANCET为98.4， BMJ为93.6，NEJM为96.2，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。

309 0

[GetPortalCommentsPageByObjectIdResponse(id=2226689, encodeId=7bd42226689b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：内科 经验分享：投稿前先是做了大量的工作，查了很多资料。 投稿后，大概一个多月吧，通知说文章被考虑了，要每个作者填写协议。 后面差不多过了2周时间，说准备接受 然后给了修改，编辑也很认真负责。 大概又过了12天，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 真是太意外了，感觉自己是运气爆棚😏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820006, createdTime=Thu Sep 19 23:26:05 CST 2024, time=2024-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256815, encodeId=94ec225681582, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿周期较长，2-3个月（部分稿件可能需要更长时间，合理安排时间） JAMA接受多种类型的稿件，包括原创研究、系统综述、病例报告等。其中，原创研究需具有创新性，强调多中心设计、随机对照双盲设计。 同时大家在写作时如果引用文献等话要引用近5年文献，同时图表分辨率要达到300dpi，大小最好不要超过10MB。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 22:43:59 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241748, encodeId=52872241e48fe, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学综合 经验分享：简单记录一下，我的个人经验希望能帮到大家。首先在投稿前要做足准备，我查了很多资料，浏览了很多平台，也看了很多往期发表的内容，也从大家经验分享中收获了很多，（感觉整个很有必要，投稿前充分了解一下该期刊）。 投稿7周后，通知说文章被考虑，然后就是作者填写协议。 又过了2周，给了修改意见。然后又过了2周左右，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 确实是挺意外了，没想过竟然真多通过了所有审稿环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:07:27 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210788, encodeId=2a3c2210e88c0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;医学综合;心血管 经验分享：JAMA在2023年度影响因子63.1，LANCET为98.4， BMJ为93.6，NEJM为96.2，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:38:34 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=514456, encodeId=b8945144562f, content=JAMA 前天投的，今天主编给了文章编号，显示under review，有这么快就送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf7e34716, createdName=hangbinglengyu, createdTime=Wed Aug 12 15:19:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142379, encodeId=c52c21423e9c6, content=偏重的研究方向：医学综合 经验分享：不知道Under Review是编辑审还是外审呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Mon Jun 12 15:56:44 CST 2023, time=2023-06-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2140958, encodeId=9832214095887, content=大胆投稿，反复修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 05 20:50:43 CST 2023, time=2023-06-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2133562, encodeId=c5a52133562e7, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：原始论著没投过，但是投了一篇Letter to the Editor，偶然间浏览杂志刚好看到一篇RCT觉得有些地方需要补充，信息缺乏，就花了一两个小时查查文献资料，结合自己的临床经验，写了一个短篇评论，投过去就没管了，大概不到一个月吧，通知说文章被考虑发表，要每个作者填写协议，然后填完大概过了十多天说准备接受，然后给我改了文章，逐字逐句的，挺认真，都是编辑和你邮件往来，大概又过了一个星期，通知We have completed our review of your Letter to the Editor and are pleased to accept it for publication in JAMA. 这也是第一次给这杂志写letter，没想到一击必中，可能运气爆棚了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=538, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160701/IMG57766D0F679469828.jpg, createdBy=d47d28603, createdName=200750383, createdTime=Sat May 13 16:38:33 CST 2023, time=2023-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=544655, encodeId=5518544655ff, content=请求帮助，谁知道这个杂志怎么注册？为什么我要投稿，注册用户，怎么都注册不了？求高人指点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2667, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc8b41136, createdName=chunyangjiang, createdTime=Thu Jul 20 16:14:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544482, encodeId=9b5d544482a9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2015-08-12 hangbinglengyu

JAMA 前天投的，今天主编给了文章编号，显示under review，有这么快就送审么？

2837 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226689, encodeId=7bd42226689b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：内科 经验分享：投稿前先是做了大量的工作，查了很多资料。 投稿后，大概一个多月吧，通知说文章被考虑了，要每个作者填写协议。 后面差不多过了2周时间，说准备接受 然后给了修改，编辑也很认真负责。 大概又过了12天，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 真是太意外了，感觉自己是运气爆棚😏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820006, createdTime=Thu Sep 19 23:26:05 CST 2024, time=2024-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256815, encodeId=94ec225681582, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿周期较长，2-3个月（部分稿件可能需要更长时间，合理安排时间） JAMA接受多种类型的稿件，包括原创研究、系统综述、病例报告等。其中，原创研究需具有创新性，强调多中心设计、随机对照双盲设计。 同时大家在写作时如果引用文献等话要引用近5年文献，同时图表分辨率要达到300dpi，大小最好不要超过10MB。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 22:43:59 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241748, encodeId=52872241e48fe, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学综合 经验分享：简单记录一下，我的个人经验希望能帮到大家。首先在投稿前要做足准备，我查了很多资料，浏览了很多平台，也看了很多往期发表的内容，也从大家经验分享中收获了很多，（感觉整个很有必要，投稿前充分了解一下该期刊）。 投稿7周后，通知说文章被考虑，然后就是作者填写协议。 又过了2周，给了修改意见。然后又过了2周左右，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 确实是挺意外了，没想过竟然真多通过了所有审稿环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:07:27 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210788, encodeId=2a3c2210e88c0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;医学综合;心血管 经验分享：JAMA在2023年度影响因子63.1，LANCET为98.4， BMJ为93.6，NEJM为96.2，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:38:34 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=514456, encodeId=b8945144562f, content=JAMA 前天投的，今天主编给了文章编号，显示under review，有这么快就送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf7e34716, createdName=hangbinglengyu, createdTime=Wed Aug 12 15:19:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142379, encodeId=c52c21423e9c6, content=偏重的研究方向：医学综合 经验分享：不知道Under Review是编辑审还是外审呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Mon Jun 12 15:56:44 CST 2023, time=2023-06-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2140958, encodeId=9832214095887, content=大胆投稿，反复修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 05 20:50:43 CST 2023, time=2023-06-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2133562, encodeId=c5a52133562e7, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：原始论著没投过，但是投了一篇Letter to the Editor，偶然间浏览杂志刚好看到一篇RCT觉得有些地方需要补充，信息缺乏，就花了一两个小时查查文献资料，结合自己的临床经验，写了一个短篇评论，投过去就没管了，大概不到一个月吧，通知说文章被考虑发表，要每个作者填写协议，然后填完大概过了十多天说准备接受，然后给我改了文章，逐字逐句的，挺认真，都是编辑和你邮件往来，大概又过了一个星期，通知We have completed our review of your Letter to the Editor and are pleased to accept it for publication in JAMA. 这也是第一次给这杂志写letter，没想到一击必中，可能运气爆棚了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=538, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160701/IMG57766D0F679469828.jpg, createdBy=d47d28603, createdName=200750383, createdTime=Sat May 13 16:38:33 CST 2023, time=2023-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=544655, encodeId=5518544655ff, content=请求帮助，谁知道这个杂志怎么注册？为什么我要投稿，注册用户，怎么都注册不了？求高人指点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2667, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc8b41136, createdName=chunyangjiang, createdTime=Thu Jul 20 16:14:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544482, encodeId=9b5d544482a9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2023-06-12 hhyncgyzscygm 来自北京

偏重的研究方向：医学综合
经验分享：不知道Under Review是编辑审还是外审呢

519 0

[GetPortalCommentsPageByObjectIdResponse(id=2226689, encodeId=7bd42226689b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：内科 经验分享：投稿前先是做了大量的工作，查了很多资料。 投稿后，大概一个多月吧，通知说文章被考虑了，要每个作者填写协议。 后面差不多过了2周时间，说准备接受 然后给了修改，编辑也很认真负责。 大概又过了12天，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 真是太意外了，感觉自己是运气爆棚😏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820006, createdTime=Thu Sep 19 23:26:05 CST 2024, time=2024-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256815, encodeId=94ec225681582, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿周期较长，2-3个月（部分稿件可能需要更长时间，合理安排时间） JAMA接受多种类型的稿件，包括原创研究、系统综述、病例报告等。其中，原创研究需具有创新性，强调多中心设计、随机对照双盲设计。 同时大家在写作时如果引用文献等话要引用近5年文献，同时图表分辨率要达到300dpi，大小最好不要超过10MB。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 22:43:59 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241748, encodeId=52872241e48fe, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学综合 经验分享：简单记录一下，我的个人经验希望能帮到大家。首先在投稿前要做足准备，我查了很多资料，浏览了很多平台，也看了很多往期发表的内容，也从大家经验分享中收获了很多，（感觉整个很有必要，投稿前充分了解一下该期刊）。 投稿7周后，通知说文章被考虑，然后就是作者填写协议。 又过了2周，给了修改意见。然后又过了2周左右，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 确实是挺意外了，没想过竟然真多通过了所有审稿环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:07:27 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210788, encodeId=2a3c2210e88c0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;医学综合;心血管 经验分享：JAMA在2023年度影响因子63.1，LANCET为98.4， BMJ为93.6，NEJM为96.2，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:38:34 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=514456, encodeId=b8945144562f, content=JAMA 前天投的，今天主编给了文章编号，显示under review，有这么快就送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf7e34716, createdName=hangbinglengyu, createdTime=Wed Aug 12 15:19:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142379, encodeId=c52c21423e9c6, content=偏重的研究方向：医学综合 经验分享：不知道Under Review是编辑审还是外审呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Mon Jun 12 15:56:44 CST 2023, time=2023-06-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2140958, encodeId=9832214095887, content=大胆投稿，反复修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 05 20:50:43 CST 2023, time=2023-06-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2133562, encodeId=c5a52133562e7, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：原始论著没投过，但是投了一篇Letter to the Editor，偶然间浏览杂志刚好看到一篇RCT觉得有些地方需要补充，信息缺乏，就花了一两个小时查查文献资料，结合自己的临床经验，写了一个短篇评论，投过去就没管了，大概不到一个月吧，通知说文章被考虑发表，要每个作者填写协议，然后填完大概过了十多天说准备接受，然后给我改了文章，逐字逐句的，挺认真，都是编辑和你邮件往来，大概又过了一个星期，通知We have completed our review of your Letter to the Editor and are pleased to accept it for publication in JAMA. 这也是第一次给这杂志写letter，没想到一击必中，可能运气爆棚了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=538, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160701/IMG57766D0F679469828.jpg, createdBy=d47d28603, createdName=200750383, createdTime=Sat May 13 16:38:33 CST 2023, time=2023-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=544655, encodeId=5518544655ff, content=请求帮助，谁知道这个杂志怎么注册？为什么我要投稿，注册用户，怎么都注册不了？求高人指点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2667, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc8b41136, createdName=chunyangjiang, createdTime=Thu Jul 20 16:14:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544482, encodeId=9b5d544482a9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2023-06-05 4031828 来自河南省

大胆投稿，反复修改

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2226689, encodeId=7bd42226689b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：内科 经验分享：投稿前先是做了大量的工作，查了很多资料。 投稿后，大概一个多月吧，通知说文章被考虑了，要每个作者填写协议。 后面差不多过了2周时间，说准备接受 然后给了修改，编辑也很认真负责。 大概又过了12天，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 真是太意外了，感觉自己是运气爆棚😏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820006, createdTime=Thu Sep 19 23:26:05 CST 2024, time=2024-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256815, encodeId=94ec225681582, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿周期较长，2-3个月（部分稿件可能需要更长时间，合理安排时间） JAMA接受多种类型的稿件，包括原创研究、系统综述、病例报告等。其中，原创研究需具有创新性，强调多中心设计、随机对照双盲设计。 同时大家在写作时如果引用文献等话要引用近5年文献，同时图表分辨率要达到300dpi，大小最好不要超过10MB。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 22:43:59 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241748, encodeId=52872241e48fe, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学综合 经验分享：简单记录一下，我的个人经验希望能帮到大家。首先在投稿前要做足准备，我查了很多资料，浏览了很多平台，也看了很多往期发表的内容，也从大家经验分享中收获了很多，（感觉整个很有必要，投稿前充分了解一下该期刊）。 投稿7周后，通知说文章被考虑，然后就是作者填写协议。 又过了2周，给了修改意见。然后又过了2周左右，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 确实是挺意外了，没想过竟然真多通过了所有审稿环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:07:27 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210788, encodeId=2a3c2210e88c0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;医学综合;心血管 经验分享：JAMA在2023年度影响因子63.1，LANCET为98.4， BMJ为93.6，NEJM为96.2，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:38:34 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=514456, encodeId=b8945144562f, content=JAMA 前天投的，今天主编给了文章编号，显示under review，有这么快就送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf7e34716, createdName=hangbinglengyu, createdTime=Wed Aug 12 15:19:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142379, encodeId=c52c21423e9c6, content=偏重的研究方向：医学综合 经验分享：不知道Under Review是编辑审还是外审呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Mon Jun 12 15:56:44 CST 2023, time=2023-06-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2140958, encodeId=9832214095887, content=大胆投稿，反复修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 05 20:50:43 CST 2023, time=2023-06-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2133562, encodeId=c5a52133562e7, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：原始论著没投过，但是投了一篇Letter to the Editor，偶然间浏览杂志刚好看到一篇RCT觉得有些地方需要补充，信息缺乏，就花了一两个小时查查文献资料，结合自己的临床经验，写了一个短篇评论，投过去就没管了，大概不到一个月吧，通知说文章被考虑发表，要每个作者填写协议，然后填完大概过了十多天说准备接受，然后给我改了文章，逐字逐句的，挺认真，都是编辑和你邮件往来，大概又过了一个星期，通知We have completed our review of your Letter to the Editor and are pleased to accept it for publication in JAMA. 这也是第一次给这杂志写letter，没想到一击必中，可能运气爆棚了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=538, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160701/IMG57766D0F679469828.jpg, createdBy=d47d28603, createdName=200750383, createdTime=Sat May 13 16:38:33 CST 2023, time=2023-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=544655, encodeId=5518544655ff, content=请求帮助，谁知道这个杂志怎么注册？为什么我要投稿，注册用户，怎么都注册不了？求高人指点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2667, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc8b41136, createdName=chunyangjiang, createdTime=Thu Jul 20 16:14:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544482, encodeId=9b5d544482a9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2023-05-13 200750383 来自广东省

审稿速度:1.0 | 投稿命中率:5.0
经验分享：原始论著没投过，但是投了一篇Letter to the Editor，偶然间浏览杂志刚好看到一篇RCT觉得有些地方需要补充，信息缺乏，就花了一两个小时查查文献资料，结合自己的临床经验，写了一个短篇评论，投过去就没管了，大概不到一个月吧，通知说文章被考虑发表，要每个作者填写协议，然后填完大概过了十多天说准备接受，然后给我改了文章，逐字逐句的，挺认真，都是编辑和你邮件往来，大概又过了一个星期，通知We have completed our review of your Letter to the Editor and are pleased to accept it for publication in JAMA. 这也是第一次给这杂志写letter，没想到一击必中，可能运气爆棚了

538 0

[GetPortalCommentsPageByObjectIdResponse(id=2226689, encodeId=7bd42226689b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：内科 经验分享：投稿前先是做了大量的工作，查了很多资料。 投稿后，大概一个多月吧，通知说文章被考虑了，要每个作者填写协议。 后面差不多过了2周时间，说准备接受 然后给了修改，编辑也很认真负责。 大概又过了12天，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 真是太意外了，感觉自己是运气爆棚😏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820006, createdTime=Thu Sep 19 23:26:05 CST 2024, time=2024-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256815, encodeId=94ec225681582, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿周期较长，2-3个月（部分稿件可能需要更长时间，合理安排时间） JAMA接受多种类型的稿件，包括原创研究、系统综述、病例报告等。其中，原创研究需具有创新性，强调多中心设计、随机对照双盲设计。 同时大家在写作时如果引用文献等话要引用近5年文献，同时图表分辨率要达到300dpi，大小最好不要超过10MB。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 22:43:59 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241748, encodeId=52872241e48fe, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学综合 经验分享：简单记录一下，我的个人经验希望能帮到大家。首先在投稿前要做足准备，我查了很多资料，浏览了很多平台，也看了很多往期发表的内容，也从大家经验分享中收获了很多，（感觉整个很有必要，投稿前充分了解一下该期刊）。 投稿7周后，通知说文章被考虑，然后就是作者填写协议。 又过了2周，给了修改意见。然后又过了2周左右，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 确实是挺意外了，没想过竟然真多通过了所有审稿环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:07:27 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210788, encodeId=2a3c2210e88c0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;医学综合;心血管 经验分享：JAMA在2023年度影响因子63.1，LANCET为98.4， BMJ为93.6，NEJM为96.2，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:38:34 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=514456, encodeId=b8945144562f, content=JAMA 前天投的，今天主编给了文章编号，显示under review，有这么快就送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf7e34716, createdName=hangbinglengyu, createdTime=Wed Aug 12 15:19:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142379, encodeId=c52c21423e9c6, content=偏重的研究方向：医学综合 经验分享：不知道Under Review是编辑审还是外审呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Mon Jun 12 15:56:44 CST 2023, time=2023-06-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2140958, encodeId=9832214095887, content=大胆投稿，反复修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 05 20:50:43 CST 2023, time=2023-06-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2133562, encodeId=c5a52133562e7, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：原始论著没投过，但是投了一篇Letter to the Editor，偶然间浏览杂志刚好看到一篇RCT觉得有些地方需要补充，信息缺乏，就花了一两个小时查查文献资料，结合自己的临床经验，写了一个短篇评论，投过去就没管了，大概不到一个月吧，通知说文章被考虑发表，要每个作者填写协议，然后填完大概过了十多天说准备接受，然后给我改了文章，逐字逐句的，挺认真，都是编辑和你邮件往来，大概又过了一个星期，通知We have completed our review of your Letter to the Editor and are pleased to accept it for publication in JAMA. 这也是第一次给这杂志写letter，没想到一击必中，可能运气爆棚了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=538, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160701/IMG57766D0F679469828.jpg, createdBy=d47d28603, createdName=200750383, createdTime=Sat May 13 16:38:33 CST 2023, time=2023-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=544655, encodeId=5518544655ff, content=请求帮助，谁知道这个杂志怎么注册？为什么我要投稿，注册用户，怎么都注册不了？求高人指点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2667, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc8b41136, createdName=chunyangjiang, createdTime=Thu Jul 20 16:14:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544482, encodeId=9b5d544482a9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2017-07-20 chunyangjiang

请求帮助，谁知道这个杂志怎么注册？为什么我要投稿，注册用户，怎么都注册不了？求高人指点！

2667 0

[GetPortalCommentsPageByObjectIdResponse(id=2226689, encodeId=7bd42226689b2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：内科 经验分享：投稿前先是做了大量的工作，查了很多资料。 投稿后，大概一个多月吧，通知说文章被考虑了，要每个作者填写协议。 后面差不多过了2周时间，说准备接受 然后给了修改，编辑也很认真负责。 大概又过了12天，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 真是太意外了，感觉自己是运气爆棚😏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820006, createdTime=Thu Sep 19 23:26:05 CST 2024, time=2024-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256815, encodeId=94ec225681582, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿周期较长，2-3个月（部分稿件可能需要更长时间，合理安排时间） JAMA接受多种类型的稿件，包括原创研究、系统综述、病例报告等。其中，原创研究需具有创新性，强调多中心设计、随机对照双盲设计。 同时大家在写作时如果引用文献等话要引用近5年文献，同时图表分辨率要达到300dpi，大小最好不要超过10MB。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 22:43:59 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241748, encodeId=52872241e48fe, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学综合 经验分享：简单记录一下，我的个人经验希望能帮到大家。首先在投稿前要做足准备，我查了很多资料，浏览了很多平台，也看了很多往期发表的内容，也从大家经验分享中收获了很多，（感觉整个很有必要，投稿前充分了解一下该期刊）。 投稿7周后，通知说文章被考虑，然后就是作者填写协议。 又过了2周，给了修改意见。然后又过了2周左右，通知we have completed our review of your letter to the editor and are pleased to accept it for publication in jama. 确实是挺意外了，没想过竟然真多通过了所有审稿环节。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:07:27 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210788, encodeId=2a3c2210e88c0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;医学综合;心血管 经验分享：JAMA在2023年度影响因子63.1，LANCET为98.4， BMJ为93.6，NEJM为96.2，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:38:34 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=514456, encodeId=b8945144562f, content=JAMA 前天投的，今天主编给了文章编号，显示under review，有这么快就送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2837, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf7e34716, createdName=hangbinglengyu, createdTime=Wed Aug 12 15:19:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142379, encodeId=c52c21423e9c6, content=偏重的研究方向：医学综合 经验分享：不知道Under Review是编辑审还是外审呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Mon Jun 12 15:56:44 CST 2023, time=2023-06-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2140958, encodeId=9832214095887, content=大胆投稿，反复修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Mon Jun 05 20:50:43 CST 2023, time=2023-06-05, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2133562, encodeId=c5a52133562e7, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：原始论著没投过，但是投了一篇Letter to the Editor，偶然间浏览杂志刚好看到一篇RCT觉得有些地方需要补充，信息缺乏，就花了一两个小时查查文献资料，结合自己的临床经验，写了一个短篇评论，投过去就没管了，大概不到一个月吧，通知说文章被考虑发表，要每个作者填写协议，然后填完大概过了十多天说准备接受，然后给我改了文章，逐字逐句的，挺认真，都是编辑和你邮件往来，大概又过了一个星期，通知We have completed our review of your Letter to the Editor and are pleased to accept it for publication in JAMA. 这也是第一次给这杂志写letter，没想到一击必中，可能运气爆棚了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=538, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160701/IMG57766D0F679469828.jpg, createdBy=d47d28603, createdName=200750383, createdTime=Sat May 13 16:38:33 CST 2023, time=2023-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=544655, encodeId=5518544655ff, content=请求帮助，谁知道这个杂志怎么注册？为什么我要投稿，注册用户，怎么都注册不了？求高人指点！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2667, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc8b41136, createdName=chunyangjiang, createdTime=Thu Jul 20 16:14:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544482, encodeId=9b5d544482a9, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2595, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2017-07-16 gu_8183

谁能预测明年会有多少分?

2595 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务